EGPA

With data in hand, GSK readies to expand Nucala label
BioPharma Dive
Mon, 11/28/16 - 11:41 pm
GSK
Nucala
EGPA
GSK targets a new indication for Nucala, flags PhIII success for a rare disease
Endpoints
Wed, 11/23/16 - 10:24 am
Nucala
GSK
EGPA
Rituxan may have rare-disease use
Medical Marketing and Media
Tue, 04/7/15 - 09:55 am
Rituxan
Roche
EGPA
GlaxoSmithKline eyes rare disease to widen its respiratory lead
Fierce Biotech
Fri, 02/14/14 - 01:07 pm
GSK
mepolizumab
EGPA